References
- Yu-Wai-Man P, Griffiths PG, Hudson G. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46:145–158. doi:10.1136/jmg.2007.054270.
- Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet. 1996;59:481–485.
- Jia X, Li S, Xiao X, et al. Molecular epidemiology of mtDNA mutations in 903 Chinese families suspected with Leber hereditary optic neuropathy. J Hum Genet. 2006;51(10):851–856.
- Shi H, Gao J, Pei H, et al. Adeno-associated virus- mediated gene delivery of the human ND4 complex I subunit in rabbit eyes. Clin Exp Ophthalmol. 2012;40(9):888–894. doi:10.1111/j.1442-9071.2012.02815.x.
- Cui G, Ding H, Xu Y, et al. Applications of the method of high resolution melting analysis for diagnosis of Leber’s disease and the three primary mutation spectrum of LHON in the Han Chinese population. Gene. 2013;512(1):108–112. doi:10.1016/j.gene.2012.09.110.
- Shuo Y, He H, Zhu Y, et al. Chemical and material communication between the optic nerves in rats. Clin Exp Ophthalmol. 2015;43(8):742–748. doi:10.1111/ceo.12547.
- Ran R, Yang S, Heng H, et al. retrospective analysis of characteristics of visual field damage in patients with Leber’s hereditary optic neuropathy. SpringerPlus. 2016;5:843. doi:10.1186/s40064-016-2540-7.
- Yang S, Yang H, Si-qi M, et al. Evaluation of Leber’s hereditary optic neuropathy patients prior to a gene therapy clinical trial. Medicine (Baltimore). 2016;95(40):e5110. doi:10.1097/MD.0000000000005110.
- Zhang Y, Li X, Yuan J, et al. Prognostic factors for visual acuity in patients with Leber’s hereditary optic neuropathy after rAAV2-ND4 gene therapy. Clin Exp Ophthalmol. 2019;47:774–778. doi:10.1111/ceo.13515.
- Yuan JJ, Zhang Y, Wang LL, et al. Visual field variability after gene therapy for leber’s hereditary optic neuropathy. Ophthalmic Res. 2018;60:176–184. doi:10.1159/000487485.
- Yuan J, Zhang Y, Liu H, et al. Clinical observation of patients with leber’s hereditary optic neuropathy before gene therapy. Curr Gene Ther. 2018;18:386–392. doi:10.2174/1566523218666181105125245.
- Liu HL, Yuan JJ, Tian Z, et al. What are the characteristics and progression of visual field defects in patients with Leber hereditary optic neuropathy: a prospective single-centre study in China. BMJ Open. 2019;9:e025307. doi:10.1136/bmjopen-2018-025307.
- Barboni P, Carbonelli M, Savini G, et al. Natural history of Leber’s hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology. 2010;117:623–627. doi:10.1016/j.ophtha.2009.07.026.
- Seo JH, Hwang JM. Comparison of retinal nerve fibre layers between 11778 and 14484 mutations in Leber’s hereditary optic neuropathy. Eye (Lond). 2010;24:107–111. doi:10.1038/eye.2009.36.
- Zhang Y, Huang H, Wei S, et al. Characterization of retinal nerve fiber layer thickness changes associated with Leber’s hereditary optic neuropathy by optical coherence tomography. Exp Ther Med. 2014;7:483–487. doi:10.3892/etm.2013.1430.
- Savini G, Barboni P, Valentino ML, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber’s hereditary optic neuropathy mutations. Ophthalmology. 2005;112:127–131. doi:10.1016/j.ophtha.2004.09.033.